Joanna C. Lim - Publications

BRCA Testing in Asian Patients with Ovarian Cancer: Standard Clinical Practice or Mutation Prediction Model?

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 18, 2025

Characterization of intra-tumoral microbiota from transcriptomic sequencing of Asian breast cancer.

Journal: Scientific reports

Published: April 14, 2025

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.

Journal: The Lancet regional health. Western Pacific

Published: March 20, 2025

Exploring willingness to pay out-of-pocket for genetic testing among ovarian cancer patients in Malaysia, a middle-income country in Asia.

Journal: Journal of gynecologic oncology

Published: October 22, 2024

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Journal: American journal of human genetics

Published: March 29, 2024

Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypes.

Journal: Breast cancer research : BCR

Published: January 16, 2024

Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants - an Asian study of 572 families.

Journal: The Lancet regional health. Western Pacific

Published: September 12, 2023

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer.

Journal: NPJ breast cancer

Published: August 16, 2023

Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 10, 2022

Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.

Journal: PloS one

Published: September 12, 2021

Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore.

Journal: Journal of medical genetics

Published: September 24, 2020

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.

Journal: Journal of medical genetics

Published: September 08, 2020